Clinical Trials Directory

Trials / Completed

CompletedNCT03618251

Automated Volume Assessment of Acute Stroke

Evaluation of Infarct Volumetric Software in Strokes of Less Than 24 Hours

Status
Completed
Phase
Study type
Observational
Enrollment
406 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Stroke is a common disease. It is increasingly managed in non-specialized centers. The volume of the lesion, evaluated on the diffusion weighted imaging, is a prognostic factor of clinical progression and is useful for the treatment decision. There is therefore a real interest in having a reliable software able to detect the stroke and evaluate the volume of the cerebral infarction. The aim is to provide rapid information to the interventional neuroradiologist and optimize the care of the patient. The Alberta Stroke Program Early Computed Tomography Score currently used to predict response to treatment divides the territory of the middle cerebral artery. It has a few limitations, it is unreproducible and concerns only the territory of the middle cerebral artery. Manual volumetry is a long and also not very reproducible technique. The aim of our study is to evaluate the reproducibility and diagnostic performances of the automated segmentation software based on the diffusion weighted imaging sequence, and to compare it to manual and semi-automatic measurements.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTspecific MRI sequencesMRI with B 2000 of diffusion weighted imaging and the coefficient of apparent diffusion

Timeline

Start date
2018-03-15
Primary completion
2020-09-04
Completion
2020-12-04
First posted
2018-08-07
Last updated
2021-09-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03618251. Inclusion in this directory is not an endorsement.